Pippa Hunter

Pippa Hunter
T: +44 (0) 207 246 0540
E: pippa.hunter@alantra.com

Pippa is an Analyst at Alantra.

Her chief responsibilities are to produce detailed analysis of transaction trends and to provide bespoke research to support business development and deal delivery. . 

Pippa is also a member of our Consumer sector team.

Recent deals include the sale of Vivona Brands and International Dance Supplies and advising Piper on its investment in Neom Organics.

Prior to Alantra, Pippa was an analyst at CIL Management Consultants where she worked on over 30 commercial due diligence projects across a variety of sectors. During her time at CIL, she developed a keen interest in the consumer and construction sectors, working on the sale of Original Additions to PDC Brands and Elysian Capital’s acquisition of Raymond Brown, amongst others.

She has an MSc in International Management from IE Business School in Madrid and a BSc (Hons) in Psychology from Durham University.

Outside of work, Pippa enjoys long-weekend walking holidays, tennis and trying new things.

 

Alantra appoints experienced partner to head up its UK Real Estate & Hospitality team

Alantra has appointed Hoong Wey Woon as a Partner to head up its UK Real Estate & Hospitality team.  

Alantra advises Strong Roots on securing over €15.5m of investment

Alantra advises Strong Roots, one of the UK’s fastest-growing food companies, on securing over €15.5m of investment 

Alantra advises i2S on its sale to Gfi Informatique

Alantra advises Portuguese IT firm, i2S, on its sale to Gfi Informatique 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.